Camilla Soenderby

Camilla Soenderby

Director/Board Member at BB BIOTECH AG

Net worth: - $ as of 31/05/2026

Health Technology
Distribution Services
Finance

Profile

Camilla Soenderby currently works at Affibody Medical AB, as Director, F2G Ltd., as Non-Executive Director from 2021, Abivax SA, as Independent Director from 2024, and BB Biotech AG, as Director from 2024.
Ms. Soenderby also formerly worked at Takeda Pharmaceutical Co., Ltd., as Head-Product Strategy Officer from 2019 to 2020, Shire France SAS, as Head-Global Product Strategy, Schering-Plough Ltd. (Taiwan), as General Manager, and AbbVie SAS (France), as General Manager.
Ms. Soenderby received her undergraduate degree from the University of Copenhagen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/02/2026 0 ( -.--% ) - $ 31/05/2026

Camilla Soenderby active positions

CompaniesPositionStart
BB BIOTECH AG Director/Board Member 21/03/2024
ABIVAX Director/Board Member 02/04/2024
Director/Board Member 15/09/2021
Director/Board Member -

Former positions of Camilla Soenderby

CompaniesPositionEnd
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Camilla Soenderby's experience

Training of Camilla Soenderby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Distribution Services

Distribution Services

  1. Stock Market
  2. Insiders
  3. Camilla Soenderby
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!